PINC:NSD-Premier Inc (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 21.51

Change

+0.13 (+0.61)%

Market Cap

USD 2.08B

Volume

0.38M

Analyst Target

USD 36.89
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Premier, Inc., together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions. This segment also provides the ASCENDrive programs for members to receive group purchasing programs, tiers, and prices; SURPASS Performance Group services for coordinate purchasing decisions, review utilization and achieve and maintain standardization across member's facilities; SaaS informatics products for the purchase additional elements; supply chain co-management services; purchased services contracts; direct sourcing solutions; and supply chain resiliency programs. The Performance Services segment provides technology and services platform with offerings that help optimize performance in three main areas, including clinical intelligence, margin improvement, and value-based care under the PINC AI brand; third party administrator services and management of health benefit programs under the Contigo Health brand; and digital invoicing and payables services that offers financial support services to healthcare product suppliers and service providers under the Remitra brand. The company was incorporated in 2013 and is headquartered in Charlotte, North Carolina.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-24 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
GEHC GE HealthCare Technologies Inc..

+0.08 (+0.10%)

USD 37.81B
HQY HealthEquity Inc

+0.59 (+0.62%)

USD 8.82B
TEM Tempus AI, Inc. Class A Common..

-0.12 (-0.34%)

USD 7.92B
WAY Waystar Holding Corp. Common S..

+0.83 (+2.25%)

USD 4.47B
BTSG BrightSpring Health Services, ..

+0.04 (+0.23%)

USD 3.18B
PRVA Privia Health Group Inc

-0.01 (-0.05%)

USD 2.52B
OMCL Omnicell Inc

-1.30 (-2.92%)

USD 2.13B
WGS GeneDx Holdings Corp.

+1.00 (+1.31%)

USD 2.03B
GDRX Goodrx Holdings Inc

-0.03 (-0.66%)

USD 1.87B
CERT Certara Inc

-0.04 (-0.37%)

USD 1.75B

ETFs Containing PINC

BSMC 2023 EFT Series Trust - B.. 2.77 % 0.00 %

+0.27 (+0.88%)

USD 0.08B
FHH:CA First Trust AlphaDEX US H.. 2.60 % 0.77 %

+0.28 (+0.88%)

CAD 0.01B
FXH First Trust Health Care A.. 2.54 % 0.63 %

+0.21 (+0.88%)

USD 1.09B
XHS SPDR® S&P Health Care Se.. 2.29 % 0.35 %

+0.28 (+0.88%)

USD 0.07B
OUSM O’Shares U.S. Small-Cap.. 2.09 % 0.48 %

+0.29 (+0.88%)

USD 0.85B
ROSC Hartford Multifactor Smal.. 0.00 % 0.00 %

+0.46 (+0.88%)

USD 0.04B
FHH-F:CA First Trust AlphaDEX U.S... 0.00 % 0.00 %

N/A

CAD 0.01B

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -3.80% 65% D 45% F
Dividend Return 3.76% 56% F 64% D
Total Return -0.04% 65% D 46% F
Trailing 12 Months  
Capital Gain -4.82% 64% D 43% F
Dividend Return 3.72% 56% F 63% D
Total Return -1.11% 64% D 45% F
Trailing 5 Years  
Capital Gain -43.44% 68% D+ 29% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -43.44% 68% D+ 28% F
Average Annual (5 Year Horizon)  
Capital Gain -9.30% 46% F 22% F
Dividend Return -7.36% 51% F 23% F
Total Return 1.94% 50% F 49% F
Risk Return Profile  
Volatility (Standard Deviation) 18.02% 97% N/A 80% B-
Risk Adjusted Return -40.86% 39% F 16% F
Market Capitalization 2.08B 84% B 79% B-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.